Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008
Date:8/6/2008

, 2007. The increase is due to the additional debt incurred to finance the acquisition of Merck Generics.

Other income, net, was $7.9 million for the three months ended June 30, 2008, compared to net expense of $36.4 million in the same prior year period. The comparable quarter of 2007 included a $57.5 million non-cash mark to market unrealized loss on a deal-contingent foreign currency option contract that was entered into for the then pending acquisition of Merck Generics. Excluding this unrealized loss, the decrease in other income, net, in the current year is due primarily to lower interest and dividend income as a result of lower cash and available for sale securities.

Non-GAAP Financial Measures

Mylan is disclosing non-GAAP financial measures when providing financial results. Primarily due to acquisitions, Mylan believes that an evaluation of its ongoing operations (and comparisons of its current operations with historical and future operations) would be difficult if the disclosure of its financial results were limited to financial measures prepared only in accordance with accounting principles generally accepted in the United States (GAAP). In addition to disclosing its financial results determined in accordance with GAAP, Mylan is disclosing non-GAAP results that exclude items such as amortization expense and other costs directly associated with the acquisitions as well as certain other non-recurring expenses in order to supplement investors' and other readers' understanding and assessment of the Company's financial performance because the Company's management uses these measures internally for forecasting, budgeting and measuring its operating performance. Whenever Mylan uses such a non-GAAP measure, it will provide a reconciliation of non-GAAP financial measures to the most closely applicable GAAP financial measure. Investors and other readers are encouraged to review the related GAAP financial measures and the reconciliation of non-GA
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Mylan Announces Final FDA Approval for Carvedilol Tablets
3. Mylan Announces Tentative FDA Approval for Topiramate Capsules
4. Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
5. Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
8. Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
9. Mylan Announces Appointment of Harry A. Korman as President, North America
10. Mylan Announces Appointment of John Montgomery as President, Asia Pacific
11. Mylan Announces Management of Specialty Business, Dey L.P.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- Aflac Incorporated announced today that it has ... notes with a coupon of 6.9%. The notes ... to yield 6.984%. The company anticipates using the ... general corporate purposes. ,, Commenting on the pricing ... Chief Financial Officer Kriss Cloninger III commented: "This ...
(Date:12/14/2009)... Calif., Dec. 14 Tough Enough To Wear ... breast cancer, celebrated its fifth anniversary at the ... the Wrangler National Finals Rodeo (Wrangler NFR) in ... with rough-and-tumble rodeo cowboys, the support of the ... the sold-out crowd sported pink shirts, hats, bracelets ...
(Date:12/14/2009)... in Canada for 13 years under government controlled health care, before ... economy. In speaking engagements and in his new book, Health Reform: ... fragility of such a system and its threat to real health ... ... Lee Kurisko , a diagnostic radiologist from Minnesota, warns Americans not ...
(Date:12/14/2009)... -- Skilled nursing facilities (SNFs) in Ohio are making ... deal with a 92 percent increase in the state-imposed ... $12.01 per bed per day, scheduled for December 15. ... pay an additional $17,520 to the state each month, ... $438,365 yearly. ,, Nearly 96 percent of skilled nursing ...
(Date:12/14/2009)... -- Grubb & Ellis Healthcare REIT II, Inc. announced today ... to stockholders of record as of the close of business ... 2010 and ending on Feb. 28, 2010. The distributions ... year and will be equal to an annualized distribution rate ... share. These distributions will be aggregated and paid in ...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 4Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 2Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 3
... Canadian Regulatory Authorities Approve 3f(R) Aortic Bioprosthesis for Sale ... ... Company Updates Financial Outlook for 2008, MINNEAPOLIS, Jan. 31 ... products and services, today announced it has received a request,for additional information and ...
... Patients treated at top-rated hospitals nationwide are nearly ... those admitted to all other hospitals, according to ... independent healthcare ratings organization. Patients who undergo surgery ... five percent lower risk of complications during their ...
... autoimmune disease, tend to die younger and, largely ... this increasingly recognized fact is that inflammation promotes ... the C-reactive protein (CRP) level has been shown ... However, other highly inflammatory diseasesCrohns, for exampledo not ...
... New Information Strengthens Community,s Demand to Save St. ... ... Health told the San,Francisco Chronicle in a January 27 article the reason ... Luke,s,Hospital, the South of Market facility they are trying to close:, ...
... Give Kids A Smile! events, CHICAGO, Jan. ... and on Feb. 1, more than 51,000 dental ... 500,000 children from low-income,families, at more than 2,000 ... Association,s (ADA) sixth annual Give Kids A Smile ...
... Will Emcee Event ... New York City, NEW YORK, Jan. 30 Woman,s Day ... by honoring four women who,have made significant contributions to the fight ... Insider,s Lara Spencer will emcee the event on Thursday, January,31st at ...
Other Medicine News:Health News:ATS Medical Provides Update on First Generation Tissue Valve Approval 2Health News:ATS Medical Provides Update on First Generation Tissue Valve Approval 3Health News:Top hospitals have 27 percent lower mortality, annual HealthGrades study finds 2Health News:Top hospitals have 27 percent lower mortality, annual HealthGrades study finds 3Health News:The HLA-DRB1 gene and premature death in rheumatoid arthritis 2Health News:The HLA-DRB1 gene and premature death in rheumatoid arthritis 3Health News:Open Wide! Nation's Dentists Address Access With Free Care for Kids 2Health News:Open Wide! Nation's Dentists Address Access With Free Care for Kids 3Health News:Woman's Day Presents the 5th Annual 'Red Dress Awards' Honoring Women Who Are Leaders in the Fight Against Heart Disease 2Health News:Woman's Day Presents the 5th Annual 'Red Dress Awards' Honoring Women Who Are Leaders in the Fight Against Heart Disease 3Health News:Woman's Day Presents the 5th Annual 'Red Dress Awards' Honoring Women Who Are Leaders in the Fight Against Heart Disease 4
(Date:12/14/2009)... 14 Transcept Pharmaceuticals, Inc. (Nasdaq: ... a Notice of Allowance from the United States ... U.S. patent application no. 11/060,641, which covers the ... tartrate sublingual tablet), the lead Transcept product candidate. ... earlier than February 2025. ,, "This is the ...
(Date:12/14/2009)... Dec. 14 In response to an ... 2009, in which the Agency recommended that healthcare ... (SS1) sterile processing system, hospitals throughout the U.S. ... alternatives to that product. According to the FDA, ... SS1 that may affect the safety or the ...
(Date:12/14/2009)... directors of Eli Lilly and Company (NYSE: ... quarter of 2010 of $0.49 a share on outstanding ... March 10, 2010 to shareholders of record at the ... ,, Lilly, a leading innovation-driven corporation, is developing a ... research from its own worldwide laboratories and from collaborations ...
Breaking Medicine Technology:Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 2Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 3Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 4ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 2ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 3New Program to Bring University of Florida Incubator Companies Millions in New Contracts 14804 1New Program to Bring University of Florida Incubator Companies Millions in New Contracts 14804 2New Program to Bring University of Florida Incubator Companies Millions in New Contracts 14804 3New Program to Bring University of Florida Incubator Companies Millions in New Contracts 14804 4SourceMedical Earns Cardinal Health Innovation Award 61207 1SourceMedical Earns Cardinal Health Innovation Award 61207 2The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 1The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 2The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 3The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 4The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 5The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 6The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 7
... for 4Q07/1Q08, DALLAS, Aug. 20 Access ... update on the clinical,development plan of ProLindac, its ... additional human clinical trials to be initiated in,late ... recurrent ovarian,cancer patients, designed to optimize single agent ...
... 17 AutoGenomics, a leader in,developing automated molecular ... that it submitted to the FDA for 510(k) ... the Harvard Medical,School-Partners HealthCare Center for Genetics and ... a drug prescribed to help prevent,blood clots. With ...
Other Medicine Technology:Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 2Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 3Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 4Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity 2
... The Plan-Neofluar 63x/1.25 Oil Ph3 ... reflected-light reflection contrast. This method ... brightfield microscopy, such as cells ... a Petri dish. Moreover, this ...
... high-power, apochromatically corrected objectives ... the most exacting demands ... are suitable for visual ... 25 mm and feature ...
... redesigned by Nikon allowing the contrast direction ... the objective. That direction, once set, is ... 10x to 40x.,Apodized phase contrast objectives,Nikon's Apodized ... image by reducing internal reflections. The result ...
... Featuring an extra-high transmission rate, especially ... comparable to the CFI plan Achromat ... fluorescence observation and photomicrography. Because ... function as multipurpose objectives for brightfield, ...
Medicine Products: